Jelena Kovačić

Publication Activity (10 Years)

Years Active: 2022-2023
Publications (10 Years): 7

Top Topics

Ulcerative Colitis

Top Venues

Pharmaceuticals (Basel, Switzerland)

Acta pharmaceutica (Zagreb, Croatia)

This page only lists publications with an associated author ORCID identifier.

Publications

Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, Ana Mornar
Size exclusion chromatography as green support for forced degradation study of adalimumab. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, Ana Mornar
Size exclusion chromatography as green support for forced degradation study of adalimumab. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Jelena Kovačić, Daniela Amidžić Klarić, Nikša Turk, Ana Mornar
Size exclusion chromatography as green support for forced degradation study of adalimumab. Acta pharmaceutica (Zagreb, Croatia) 73 (4) (2023)
Daniela Amidžić Klarić, Jelena Kovačić, Mario-Livio Jeličić, Snježana Zubčić, Vladimir Stankov, Marija Gulan Čičak, Boris Bučar, Ilija Klarić, Ana Mornar
Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Daniela Amidžić Klarić, Jelena Kovačić, Mario-Livio Jeličić, Snježana Zubčić, Vladimir Stankov, Marija Gulan Čičak, Boris Bučar, Ilija Klarić, Ana Mornar
Assessment of Physicochemical Parameters and Contaminants in Herbal Dietary Supplements Used in the Treatment of Inflammatory Bowel Disease. Pharmaceuticals (Basel, Switzerland) 16 (6) (2023)
Mario-Livio Jeličić, Daniela Amidžić Klarić, Jelena Kovačić, Donatella Verbanac, Ana Mornar
Accessing Lipophilicity and Biomimetic Chromatography Profile of Biologically Active Ingredients of Botanicals Used in the Treatment of Inflammatory Bowel Disease. Pharmaceuticals (Basel, Switzerland) 15 (8) (2022)
Mario-Livio Jeličić, Jelena Kovačić, Matija Cvetnić, Ana Mornar, Daniela Amidžić Klarić
Antioxidant Activity of Pharmaceuticals: Predictive QSAR Modeling for Potential Therapeutic Strategy. Pharmaceuticals (Basel, Switzerland) 15 (7) (2022)